Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Lilly (Eli) (LLY) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareDrug Manufacturers - GeneralLLY

Closing price · Nov 19, 2026 $1,353.51 -2.1% on the day · +29.6% over 12 months 52-week range $848.53 – $1,443.50
Get LLY alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling5last 12 months
Reported sales$1.03B6 of 250 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 3, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Anat Hakim, Evp, Gc & Secretary sold 5,000 shares at $1,402.52 ($7.0M).

Trade date
Nov 2, 2026
Disclosed to the SEC
Nov 3, 2026
Type
Pre-planned sale, 10b5-1 (code S)

Read the original SEC filing ↗All LLY insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

LLY insider transactions (Form 4)

Open-market purchases and sales. 142 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 3SEC Anat HakimEvp, Gc & Secretary Sell Plan 5,0004,137 held (−55%) $1,402.52 $7.0M -3.5% —
Aug 18SEC Patrik JonssonPresident Sell Plan 6,50054,147 held (−11%) $1,175.10 $7.6M +15.2% —
Aug 11SEC Donald A. ZakrowskiSvp, Finance, & Cao Sell Plan 2,0001,526 held (−57%) $1,185.01 $2.4M +14.2% —
Aug 10SEC Anat HakimEvp, Gc & Secretary Sell Plan 5,00011,875 held (−30%) $1,190.00 $6.0M +13.7% —
Jun 11SEC Ilya YuffaEvp&Pres, Lly Usa&Global Capab Sell Plan 2,50029,804 held (−8%) $1,150.77 $2.9M +17.6% —
May 7SEC Lilly Endowment IncFormer 10% Shareholder Sell 13,62091,883,358 held (−0%) $995.23 $13.6M +36.0% —
May 7SEC Lilly Endowment IncFormer 10% Shareholder Sell 2,20891,881,150 held (−0%) $996.18 $2.2M +35.9% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 40,95692,023,036 held (−0%) $1,103.31 $45.2M +22.7% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 34,43492,063,992 held (−0%) $1,102.41 $38.0M +22.8% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 24,36291,977,632 held (−0%) $1,105.46 $26.9M +22.4% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 21,04292,001,994 held (−0%) $1,104.40 $23.2M +22.6% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 20,66892,098,426 held (−0%) $1,101.42 $22.8M +22.9% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 20,44792,134,031 held (−0%) $1,099.36 $22.5M +23.1% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 16,65091,947,281 held (−0%) $1,107.37 $18.4M +22.2% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 14,93792,119,094 held (−0%) $1,100.46 $16.4M +23.0% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 13,70191,963,931 held (−0%) $1,106.42 $15.2M +22.3% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 13,24791,934,034 held (−0%) $1,108.41 $14.7M +22.1% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 9,57392,154,478 held (−0%) $1,098.55 $10.5M +23.2% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 9,05391,906,267 held (−0%) $1,113.77 $10.1M +21.5% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 8,51391,925,521 held (−0%) $1,109.32 $9.4M +22.0% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 7,68492,180,547 held (−0%) $1,086.75 $8.4M +24.5% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 6,40892,164,051 held (−0%) $1,097.41 $7.0M +23.3% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 4,65291,915,320 held (−0%) $1,112.43 $5.2M +21.7% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 4,34291,901,925 held (−0%) $1,114.37 $4.8M +21.5% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 3,57592,174,972 held (−0%) $1,090.18 $3.9M +24.2% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 3,46491,922,057 held (−0%) $1,110.37 $3.8M +21.9% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 2,73791,896,978 held (−0%) $1,116.69 $3.1M +21.2% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 2,21091,899,715 held (−0%) $1,115.76 $2.5M +21.3% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 2,08591,919,972 held (−0%) $1,111.21 $2.3M +21.8% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 1,32292,171,354 held (−0%) $1,093.58 $1.4M +23.8% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 1,22492,173,748 held (−0%) $1,091.05 $1.3M +24.1% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 1,07292,172,676 held (−0%) $1,092.56 $1.2M +23.9% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 1,07092,179,477 held (−0%) $1,087.80 $1.2M +24.4% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 93092,178,547 held (−0%) $1,088.97 $1.0M +24.3% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 89592,188,231 held (−0%) $1,085.11 $971K +24.7% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 47592,170,459 held (−0%) $1,095.74 $520K +23.5% —
Jan 8SEC Lilly Endowment Inc10% Owner Sell 42092,170,934 held (−0%) $1,094.70 $460K +23.6% —
Jan 6SEC Lilly Endowment Inc10% Owner Sell 1,39092,189,126 held (−0%) $1,085.01 $1.5M +24.7% —
Dec 30SEC Lilly Endowment Inc10% Owner Sell 3,59392,190,516 held (−0%) $1,085.04 $3.9M +24.7% —
Dec 29SEC Lilly Endowment Inc10% Owner Sell 2,62992,194,109 held (−0%) $1,085.17 $2.9M +24.7% —
Dec 29SEC Lilly Endowment Inc10% Owner Sell 24092,196,738 held (−0%) $1,085.04 $260K +24.7% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 18,25492,299,689 held (−0%) $1,092.06 $19.9M +23.9% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 11,85492,245,486 held (−0%) $1,101.45 $13.1M +22.9% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 9,24992,198,318 held (−0%) $1,109.45 $10.3M +22.0% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 9,05092,290,639 held (−0%) $1,093.16 $9.9M +23.8% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 8,52792,257,340 held (−0%) $1,100.34 $9.4M +23.0% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 7,79492,212,610 held (−0%) $1,107.48 $8.6M +22.2% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 7,45692,238,030 held (−0%) $1,102.35 $8.2M +22.8% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 6,54592,265,867 held (−0%) $1,099.48 $7.2M +23.1% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 6,50892,336,650 held (−0%) $1,086.94 $7.1M +24.5% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 6,27492,231,756 held (−0%) $1,103.58 $6.9M +22.6% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 6,24692,284,393 held (−0%) $1,094.03 $6.8M +23.7% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 5,92792,317,943 held (−0%) $1,091.12 $6.5M +24.0% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 5,60492,343,158 held (−0%) $1,086.07 $6.1M +24.6% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 5,58992,331,061 held (−0%) $1,087.96 $6.1M +24.4% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 5,28492,325,777 held (−0%) $1,088.91 $5.8M +24.3% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 5,19692,226,560 held (−0%) $1,104.41 $5.7M +22.6% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 5,04392,207,567 held (−0%) $1,108.71 $5.6M +22.1% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 4,63992,272,412 held (−0%) $1,098.32 $5.1M +23.2% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 4,19892,277,051 held (−0%) $1,097.44 $4.6M +23.3% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 3,66292,220,404 held (−0%) $1,106.57 $4.1M +22.3% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 3,06992,348,762 held (−0%) $1,084.70 $3.3M +24.8% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 2,49492,224,066 held (−0%) $1,105.32 $2.8M +22.5% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 2,48192,357,190 held (−0%) $1,073.73 $2.7M +26.1% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 2,08392,282,310 held (−0%) $1,094.79 $2.3M +23.6% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 1,90792,323,870 held (−0%) $1,089.85 $2.1M +24.2% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 1,60692,351,991 held (−0%) $1,081.90 $1.7M +25.1% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 1,34092,196,978 held (−0%) $1,110.53 $1.5M +21.9% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 1,26092,354,248 held (−0%) $1,079.37 $1.4M +25.4% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 1,06192,281,249 held (−0%) $1,096.33 $1.2M +23.5% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 88292,356,308 held (−0%) $1,076.00 $949K +25.8% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 80092,355,508 held (−0%) $1,077.99 $862K +25.6% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 65192,353,597 held (−0%) $1,080.73 $704K +25.2% —
Nov 26SEC Lilly Endowment Inc10% Owner Sell 16092,351,831 held (−0%) $1,082.93 $173K +25.0% —
Nov 25SEC Lilly Endowment Inc10% Owner Sell 120,01692,381,962 held (−0%) $1,068.17 $128M +26.7% —
Nov 25SEC Lilly Endowment Inc10% Owner Sell 14,10592,367,857 held (−0%) $1,069.48 $15.1M +26.6% —
Nov 25SEC Lilly Endowment Inc10% Owner Sell 2,95492,359,671 held (−0%) $1,073.60 $3.2M +26.1% —
Nov 25SEC Lilly Endowment Inc10% Owner Sell 2,77892,365,079 held (−0%) $1,070.35 $3.0M +26.5% —
Nov 25SEC Lilly Endowment Inc10% Owner Sell 1,71092,363,369 held (−0%) $1,071.37 $1.8M +26.3% —
Nov 25SEC Lilly Endowment Inc10% Owner Sell 74492,362,625 held (−0%) $1,072.78 $798K +26.2% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 23,91692,542,676 held (−0%) $1,059.66 $25.3M +27.7% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 10,49292,524,602 held (−0%) $1,061.56 $11.1M +27.5% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 9,87192,597,433 held (−0%) $1,050.27 $10.4M +28.9% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 9,72992,566,592 held (−0%) $1,058.46 $10.3M +27.9% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 9,05192,515,551 held (−0%) $1,062.52 $9.6M +27.4% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 8,57692,506,975 held (−0%) $1,063.57 $9.1M +27.3% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 7,58292,535,094 held (−0%) $1,060.53 $8.0M +27.6% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 5,50692,591,927 held (−0%) $1,051.48 $5.8M +28.7% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 5,06492,576,321 held (−0%) $1,057.58 $5.4M +28.0% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 3,37892,503,597 held (−0%) $1,064.43 $3.6M +27.2% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 2,88592,589,042 held (−0%) $1,052.36 $3.0M +28.6% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 2,49592,582,931 held (−0%) $1,055.45 $2.6M +28.2% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 1,98792,587,055 held (−0%) $1,053.46 $2.1M +28.5% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 1,62992,585,426 held (−0%) $1,054.42 $1.7M +28.4% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 1,54692,581,385 held (−0%) $1,056.40 $1.6M +28.1% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 1,45992,502,138 held (−0%) $1,065.57 $1.6M +27.0% —
Nov 24SEC Lilly Endowment Inc10% Owner Sell 16092,501,978 held (−0%) $1,066.15 $171K +27.0% —
Nov 21SEC Lilly Endowment Inc10% Owner Sell 16,84592,627,607 held (−0%) $1,050.36 $17.7M +28.9% —
Nov 21SEC Lilly Endowment Inc10% Owner Sell 6,70192,620,906 held (−0%) $1,051.37 $7.0M +28.7% —
Nov 21SEC Lilly Endowment Inc10% Owner Sell 6,04792,614,859 held (−0%) $1,052.55 $6.4M +28.6% —
Nov 21SEC Lilly Endowment Inc10% Owner Sell 3,70292,611,157 held (−0%) $1,053.52 $3.9M +28.5% —
Nov 21SEC Lilly Endowment Inc10% Owner Sell 3,18892,607,969 held (−0%) $1,054.51 $3.4M +28.4% —
Nov 21SEC Lilly Endowment Inc10% Owner Sell 66592,607,304 held (−0%) $1,055.39 $702K +28.2% —
Nov 20SEC Lilly Endowment Inc10% Owner Sell 96,51692,715,462 held (−0%) $1,050.21 $101M +28.9% —
Nov 20SEC Lilly Endowment Inc10% Owner Sell 28,76892,686,694 held (−0%) $1,051.43 $30.2M +28.7% —
Nov 20SEC Lilly Endowment Inc10% Owner Sell 21,10792,665,587 held (−0%) $1,052.54 $22.2M +28.6% —
Nov 20SEC Lilly Endowment Inc10% Owner Sell 13,82092,651,767 held (−0%) $1,053.47 $14.6M +28.5% —
Nov 20SEC Lilly Endowment Inc10% Owner Sell 6,10992,645,658 held (−0%) $1,054.48 $6.4M +28.4% —
Nov 20SEC Lilly Endowment Inc10% Owner Sell 1,20692,644,452 held (−0%) $1,055.08 $1.3M +28.3% —
Nov 19SEC Lilly Endowment Inc10% Owner Sell 13,09792,827,399 held (−0%) $1,035.50 $13.6M +30.7% —
Nov 19SEC Lilly Endowment Inc10% Owner Sell 12,19892,840,496 held (−0%) $1,034.65 $12.6M +30.8% —
Nov 19SEC Lilly Endowment Inc10% Owner Sell 8,06792,819,332 held (−0%) $1,036.58 $8.4M +30.6% —
Nov 19SEC Lilly Endowment Inc10% Owner Sell 7,20892,859,074 held (−0%) $1,032.63 $7.4M +31.1% —
Nov 19SEC Lilly Endowment Inc10% Owner Sell 6,38092,852,694 held (−0%) $1,033.50 $6.6M +31.0% —
Nov 19SEC Lilly Endowment Inc10% Owner Sell 4,30492,867,887 held (−0%) $1,030.32 $4.4M +31.4% —
Nov 19SEC Lilly Endowment Inc10% Owner Sell 3,95092,812,958 held (−0%) $1,038.48 $4.1M +30.3% —
Nov 19SEC Lilly Endowment Inc10% Owner Sell 2,42492,816,908 held (−0%) $1,037.38 $2.5M +30.5% —
Nov 19SEC Lilly Endowment Inc10% Owner Sell 1,60592,866,282 held (−0%) $1,031.41 $1.7M +31.2% —
Nov 19SEC Lilly Endowment Inc10% Owner Sell 98092,811,978 held (−0%) $1,039.61 $1.0M +30.2% —
Nov 18SEC Lilly Endowment Inc10% Owner Sell 7,78992,874,288 held (−0%) $1,030.45 $8.0M +31.4% —
Nov 18SEC Lilly Endowment Inc10% Owner Sell 2,09792,872,191 held (−0%) $1,031.53 $2.2M +31.2% —
Nov 17SEC Lilly Endowment Inc10% Owner Sell 103,87192,956,501 held (−0%) $1,030.31 $107M +31.4% —
Nov 17SEC Lilly Endowment Inc10% Owner Sell 55,90892,900,593 held (−0%) $1,020.35 $57.0M +32.7% —
Nov 17SEC Lilly Endowment Inc10% Owner Sell 17,56792,883,026 held (−0%) $1,020.35 $17.9M +32.7% —
Nov 17SEC Lilly Endowment Inc10% Owner Sell 94992,882,077 held (−0%) $1,033.15 $980K +31.0% —
Nov 14SEC Lilly Endowment Inc10% Owner Sell 45,24693,061,732 held (−0%) $1,030.21 $46.6M +31.4% —
Nov 14SEC Lilly Endowment Inc10% Owner Sell 1,36093,060,372 held (−0%) $1,031.78 $1.4M +31.2% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 47,07393,116,934 held (−0%) $1,018.02 $47.9M +33.0% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 23,86393,334,003 held (−0%) $1,006.02 $24.0M +34.5% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 23,56893,357,866 held (−0%) $1,004.97 $23.7M +34.7% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 22,13193,381,434 held (−0%) $1,004.10 $22.2M +34.8% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 21,55993,229,271 held (−0%) $1,011.96 $21.8M +33.8% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 20,00093,270,722 held (−0%) $1,009.99 $20.2M +34.0% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 19,89293,250,830 held (−0%) $1,011.18 $20.1M +33.9% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 17,98593,290,722 held (−0%) $1,009.00 $18.1M +34.1% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 16,74993,212,522 held (−0%) $1,012.94 $17.0M +33.6% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 16,27493,184,610 held (−0%) $1,015.16 $16.5M +33.3% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 16,38393,317,620 held (−0%) $1,007.10 $16.5M +34.4% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 13,41593,171,195 held (−0%) $1,016.00 $13.6M +33.2% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 11,63893,200,884 held (−0%) $1,014.17 $11.8M +33.5% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 8,91393,308,707 held (−0%) $1,007.97 $9.0M +34.3% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 7,83393,109,101 held (−0%) $1,018.83 $8.0M +32.8% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 7,58593,403,565 held (−0%) $1,003.12 $7.6M +34.9% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 7,18893,164,007 held (−0%) $1,017.16 $7.3M +33.1% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 1,28193,107,820 held (−0%) $1,019.92 $1.3M +32.7% —
Nov 13SEC Donald A. ZakrowskiSvp, Finance, & Cao Sell Plan 1,0002,840 held (−26%) $1,010.50 $1.0M +33.9% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 84293,106,978 held (−0%) $1,021.07 $860K +32.6% —
Nov 13SEC Lilly Endowment Inc10% Owner Sell 82893,411,150 held (−0%) $1,001.93 $830K +35.1% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 33,15493,497,965 held (−0%) $990.19 $32.8M +36.7% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 30,63393,571,397 held (−0%) $986.18 $30.2M +37.2% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 26,76193,471,204 held (−0%) $991.01 $26.5M +36.6% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 22,12793,531,119 held (−0%) $989.18 $21.9M +36.8% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 13,67893,557,719 held (−0%) $987.18 $13.5M +37.1% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 12,86493,699,114 held (−0%) $972.17 $12.5M +39.2% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 12,03993,430,231 held (−0%) $996.38 $12.0M +35.8% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 11,99893,671,292 held (−0%) $973.48 $11.7M +39.0% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 11,81993,683,290 held (−0%) $972.27 $11.5M +39.2% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 11,06693,610,907 held (−0%) $984.04 $10.9M +37.5% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 10,11493,661,178 held (−0%) $974.47 $9.9M +38.9% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 9,87993,451,956 held (−0%) $993.10 $9.8M +36.3% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 9,38793,420,844 held (−0%) $997.06 $9.4M +35.8% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 9,36993,461,835 held (−0%) $992.01 $9.3M +36.4% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 8,99693,652,182 held (−0%) $975.46 $8.8M +38.8% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 8,87793,602,030 held (−0%) $985.25 $8.7M +37.4% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 7,50393,621,973 held (−0%) $983.14 $7.4M +37.7% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 5,75993,646,423 held (−0%) $976.49 $5.6M +38.6% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 5,48293,415,362 held (−0%) $998.29 $5.5M +35.6% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 5,02293,446,934 held (−0%) $994.12 $5.0M +36.2% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 4,66493,442,270 held (−0%) $995.25 $4.6M +36.0% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 4,68093,641,743 held (−0%) $977.44 $4.6M +38.5% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 4,47393,553,246 held (−0%) $987.91 $4.4M +37.0% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 4,43393,637,310 held (−0%) $978.69 $4.3M +38.3% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 3,88793,695,227 held (−0%) $973.63 $3.8M +39.0% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 3,55593,633,755 held (−0%) $979.65 $3.5M +38.2% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 3,38493,411,978 held (−0%) $999.09 $3.4M +35.5% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 2,21193,629,476 held (−0%) $981.85 $2.2M +37.9% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 2,06893,631,687 held (−0%) $980.54 $2.0M +38.0% —
Nov 12SEC Lilly Endowment Inc10% Owner Sell 11893,695,109 held (−0%) $974.09 $115K +39.0% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 31,01693,888,897 held (−0%) $925.87 $28.7M +46.2% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 15,23093,860,801 held (−0%) $929.42 $14.2M +45.6% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 13,00793,756,183 held (−0%) $945.62 $12.3M +43.1% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 12,92493,831,411 held (−0%) $932.27 $12.0M +45.2% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 12,58193,769,190 held (−0%) $944.68 $11.9M +43.3% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 10,93893,844,335 held (−0%) $931.25 $10.2M +45.3% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 10,39293,717,787 held (−0%) $952.89 $9.9M +42.0% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 10,20093,728,179 held (−0%) $952.00 $9.7M +42.2% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 9,20993,815,560 held (−0%) $934.21 $8.6M +44.9% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 8,40993,880,488 held (−0%) $927.12 $7.8M +46.0% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 6,64293,824,769 held (−0%) $933.29 $6.2M +45.0% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 6,38693,809,174 held (−0%) $935.26 $6.0M +44.7% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 5,61793,744,884 held (−0%) $948.82 $5.3M +42.7% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 5,52893,855,273 held (−0%) $930.22 $5.1M +45.5% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 5,29293,803,882 held (−0%) $936.57 $5.0M +44.5% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 4,69993,713,088 held (−0%) $953.66 $4.5M +41.9% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 4,49593,740,389 held (−0%) $949.82 $4.3M +42.5% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 4,45793,876,031 held (−0%) $928.20 $4.1M +45.8% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 4,43493,923,098 held (−0%) $922.42 $4.1M +46.7% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 3,96693,790,007 held (−0%) $940.62 $3.7M +43.9% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 3,82093,781,771 held (−0%) $943.71 $3.6M +43.4% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 3,77393,752,410 held (−0%) $946.40 $3.6M +43.0% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 3,73193,800,151 held (−0%) $937.42 $3.5M +44.4% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 3,38893,796,763 held (−0%) $938.43 $3.2M +44.2% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 2,79093,793,973 held (−0%) $939.54 $2.6M +44.1% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 2,75993,787,248 held (−0%) $941.36 $2.6M +43.8% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 2,63593,920,463 held (−0%) $923.46 $2.4M +46.6% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 2,09093,927,532 held (−0%) $921.50 $1.9M +46.9% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 2,01093,738,379 held (−0%) $950.94 $1.9M +42.3% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 1,90993,750,501 held (−0%) $947.63 $1.8M +42.8% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 1,65793,785,591 held (−0%) $942.31 $1.6M +43.6% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 1,11093,711,978 held (−0%) $954.95 $1.1M +41.7% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 62093,930,562 held (−0%) $913.78 $567K +48.1% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 55093,919,913 held (−0%) $924.35 $508K +46.4% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 55093,930,012 held (−0%) $915.33 $503K +47.9% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 27093,931,182 held (−0%) $911.00 $246K +48.6% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 23093,929,782 held (−0%) $917.26 $211K +47.6% —
Nov 6SEC Lilly Endowment Inc10% Owner Sell 16093,929,622 held (−0%) $918.12 $147K +47.4% —
Nov 5SEC Lilly Endowment Inc10% Owner Sell 52693,931,452 held (−0%) $910.72 $479K +48.6% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 29,70993,974,613 held (−0%) $896.15 $26.6M +51.0% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 26,34094,122,873 held (−0%) $884.66 $23.3M +53.0% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 25,99694,205,982 held (−0%) $877.40 $22.8M +54.3% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 21,88494,100,989 held (−0%) $885.56 $19.4M +52.8% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 19,29593,943,476 held (−0%) $898.20 $17.3M +50.7% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 18,81594,187,167 held (−0%) $878.36 $16.5M +54.1% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 17,63994,004,322 held (−0%) $895.15 $15.8M +51.2% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 17,53794,021,961 held (−0%) $894.33 $15.7M +51.3% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 17,29994,043,744 held (−0%) $891.97 $15.4M +51.7% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 15,50894,061,043 held (−0%) $891.17 $13.8M +51.9% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 14,86794,076,551 held (−0%) $890.20 $13.2M +52.0% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 11,84293,962,771 held (−0%) $897.20 $10.6M +50.9% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 10,68194,149,213 held (−0%) $883.75 $9.4M +53.2% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 10,54994,170,493 held (−0%) $880.45 $9.3M +53.7% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 6,37394,164,120 held (−0%) $881.46 $5.6M +53.6% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 6,12594,181,042 held (−0%) $879.36 $5.4M +53.9% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 5,39193,938,085 held (−0%) $899.18 $4.8M +50.5% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 4,47493,933,611 held (−0%) $900.02 $4.0M +50.4% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 4,24694,039,498 held (−0%) $893.35 $3.8M +51.5% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 4,22694,159,894 held (−0%) $882.32 $3.7M +53.4% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 4,08194,093,870 held (−0%) $888.14 $3.6M +52.4% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 3,03894,097,951 held (−0%) $886.29 $2.7M +52.7% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 2,45294,091,418 held (−0%) $888.96 $2.2M +52.3% —
Nov 4SEC Lilly Endowment Inc10% Owner Sell 1,63393,931,978 held (−0%) $900.79 $1.5M +50.3% —
Nov 3SEC Lilly Endowment Inc10% Owner Sell 197,81494,335,506 held (−0%) $862.63 $171M +56.9% —
Nov 3SEC Lilly Endowment Inc10% Owner Sell 54,19194,281,315 held (−0%) $863.42 $46.8M +56.8% —
Nov 3SEC Lilly Endowment Inc10% Owner Sell 15,67194,265,644 held (−0%) $864.53 $13.5M +56.6% —
Nov 3SEC Lilly Endowment Inc10% Owner Sell 10,35894,244,930 held (−0%) $866.55 $9.0M +56.2% —
Nov 3SEC Lilly Endowment Inc10% Owner Sell 10,35694,255,288 held (−0%) $865.60 $9.0M +56.4% —
Nov 3SEC Lilly Endowment Inc10% Owner Sell 5,44094,234,888 held (−0%) $868.44 $4.7M +55.9% —
Nov 3SEC Lilly Endowment Inc10% Owner Sell 4,60294,240,328 held (−0%) $867.54 $4.0M +56.0% —
Nov 3SEC Lilly Endowment Inc10% Owner Sell 2,91094,231,978 held (−0%) $869.47 $2.5M +55.7% —
Oct 14SEC Lilly Endowment Inc10% Owner Sell 3,19094,533,320 held (−0%) $863.37 $2.8M +56.8% —
Historical context

Similar past setups: not applicable. LLY has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with LLY in the Research Lab

LLY has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

LLY closeInsider buyInsider sale
8001,0001,2001,4001,600DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-04EEarnings release filed 2026-04-30EEarnings release filed 2026-08-05EEarnings release filed 2026-10-29Sold $260,409 on 2025-12-23 · Lilly Endowment IncSold $1,508,165 on 2026-01-05 · Lilly Endowment IncSold $2,370,020 on 2026-08-10 · Donald A. ZakrowskiSold $2,852,920 on 2025-12-24 · Lilly Endowment IncSold $2,876,925 on 2026-06-10 · Ilya YuffaSold $3,898,531 on 2025-12-29 · Lilly Endowment IncSold $5,950,000 on 2026-08-07 · Anat HakimSold $7,012,600 on 2026-11-02 · Anat HakimSold $7,638,150 on 2026-08-17 · Patrik JonssonSold $15,754,537 on 2026-05-06 · Lilly Endowment IncSold $39,067,117 on 2025-11-20 · Lilly Endowment IncSold $111,504,098 on 2025-11-21 · Lilly Endowment IncSold $152,058,091 on 2025-11-24 · Lilly Endowment IncSold $176,098,702 on 2025-11-19 · Lilly Endowment IncSold $178,423,264 on 2025-11-25 · Lilly Endowment IncSold $322,380,730 on 2026-01-07 · Lilly Endowment Inc
Bought, 12 months$0
Sold, 12 months$1.03B
Insiders buying0
Insiders selling5

Lilly (Eli) insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $1.03B of LLY stock on the open market; P/E 43.9 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

LLY insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $2.31B sold (212 trades)Q4 2025Q1 2026: $324M sold (31 trades)Q1 2026Q2 2026: $18.6M sold (3 trades)Q2 2026Q3 2026: $16.0M sold (3 trades)Q3 2026Q4 2026: $7.0M sold (1 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$7.0M1
Q3 2026—0$16.0M3
Q2 2026—0$18.6M3
Q1 2026—0$324M31
Q4 2025—0$2.31B212

Valuation, profit and volume

P/E (trailing)43.9Sector median 25.0
Market value$1204.81BDrug Manufacturers - General
Profit margin31.9%Revenue growth +38.6%
Volume vs. 50-day1.0×Last 5 sessions

Source: Yahoo Finance, as of Nov 19, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Lilly (Eli) insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $1.03B. 6 of 250 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

LLY earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Oct 29, 2026 +10.3% None +10.0%S&P -2.1% pending
Aug 5, 2026 -2.7% None +6.8%S&P -0.4% -3.4%
Apr 30, 2026 -7.7% None +13.2%S&P +1.3% +14.9%
Feb 4, 2026 -3.4% Sold $324M +1.7%S&P -1.7% -2.8%
Oct 30, 2025 +0.1% Sold $883M +6.1%S&P -0.8% +24.8%
Aug 7, 2025 -3.9% None -16.2%S&P +0.7% +16.5%
May 1, 2025 +18.7% None -8.4%S&P +2.2% -10.3%
Feb 6, 2025 +13.4% None +4.3%S&P -0.6% -0.8%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

LLY short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 41% of volume sold short2026-08-27: 46% of volume sold short2026-08-28: 46% of volume sold short2026-08-31: 41% of volume sold short2026-09-01: 48% of volume sold short2026-09-02: 33% of volume sold short2026-09-03: 37% of volume sold short2026-09-04: 45% of volume sold short2026-09-08: 44% of volume sold short2026-09-09: 46% of volume sold short2026-09-10: 48% of volume sold short2026-09-11: 38% of volume sold short2026-09-14: 45% of volume sold short2026-09-15: 47% of volume sold short2026-09-16: 39% of volume sold short2026-09-17: 43% of volume sold short2026-09-18: 50% of volume sold short2026-09-21: 50% of volume sold short2026-09-22: 46% of volume sold short2026-09-23: 52% of volume sold short2026-09-24: 43% of volume sold short2026-09-25: 48% of volume sold short2026-09-28: 48% of volume sold short2026-09-29: 50% of volume sold short2026-09-30: 60% of volume sold short2026-10-01: 43% of volume sold short2026-10-02: 50% of volume sold short2026-10-05: 45% of volume sold short2026-10-06: 50% of volume sold short2026-10-07: 47% of volume sold short2026-10-08: 57% of volume sold short2026-10-09: 44% of volume sold short2026-10-12: 49% of volume sold short2026-10-13: 42% of volume sold short2026-10-14: 45% of volume sold short2026-10-15: 41% of volume sold short2026-10-16: 55% of volume sold short2026-10-19: 45% of volume sold short2026-10-20: 49% of volume sold short2026-10-21: 48% of volume sold short2026-10-22: 52% of volume sold short2026-10-23: 37% of volume sold short2026-10-26: 57% of volume sold short2026-10-27: 33% of volume sold short2026-10-28: 40% of volume sold short2026-10-29: 34% of volume sold short2026-10-30: 28% of volume sold short2026-11-02: 25% of volume sold short2026-11-03: 32% of volume sold short2026-11-04: 30% of volume sold short2026-11-05: 25% of volume sold short2026-11-06: 27% of volume sold short2026-11-09: 30% of volume sold short2026-11-10: 42% of volume sold short2026-11-11: 34% of volume sold short2026-11-12: 48% of volume sold short2026-11-13: 43% of volume sold short2026-11-16: 41% of volume sold short2026-11-17: 38% of volume sold short2026-11-18: 51% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 51%20-day average: 36%Prior 2 months: 46%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded LLY

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
John BoozmanSenate Sold $1,001 - $15,000 Nov 21, 2025Aug 24, 2026 +28.3%
Thomas H TubervilleSenate Sold $15,001 - $50,000 Apr 15, 2025Aug 5, 2026 +80.6%
Alan ArmstrongSenate Sold $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +54.6%
Angus S King, Jr.Senate Sold $1,001 - $15,000 Feb 13, 2026Mar 24, 2026 +30.6%
Angus S King, Jr.Senate Bought $1,001 - $15,000 Dec 29, 2025Jan 26, 2026 +26.1%
Markwayne MullinSenate Bought $15,001 - $50,000 Dec 29, 2025Jan 16, 2026 +26.1%
John BoozmanSenate Sold $1,001 - $15,000 Nov 21, 2025Dec 8, 2025 +28.3%
Shelley M CapitoSenate Bought $1,001 - $15,000 Oct 24, 2025Nov 4, 2025 +65.0%
John BoozmanSenate Bought $1,001 - $15,000 Aug 22, 2025Sep 12, 2025 +91.4%
John BoozmanSenate Bought $1,001 - $15,000 Aug 11, 2025Sep 12, 2025 +114.9%

Insiders at Lilly (Eli)

InsiderBoughtSoldLast filingPast buys beat S&PScore
Lilly Endowment IncFormer 10% Shareholder — $3.53B May 7, 2026 — —
Anat HakimEvp, Gc & Secretary — $13.0M Nov 3, 2026 — —
Patrik JonssonPresident — $7.6M Nov 10, 2026 — —
Donald A. ZakrowskiSvp, Finance, & Cao — $3.4M Aug 11, 2026 — —
Ilya YuffaEvp&Pres, Lly Usa&Global Capab — $2.9M Jun 11, 2026 — —
Carolyn R. BertozziDirector — — Nov 17, 2026 — —
J. Erik FyrwaldDirector — — Nov 17, 2026 0 of 2 —
Juan R. LucianoDirector — — Nov 17, 2026 1 of 1 —
Kimberly H. JohnsonDirector — — Nov 17, 2026 — —
Jon R. MoellerDirector — — Nov 17, 2026 — —
Jamere JacksonDirector — — Nov 17, 2026 1 of 1 —
Gabrielle SulzbergerDirector — — Nov 17, 2026 — —
Ralph AlvarezDirector — — Nov 17, 2026 — —
Mary Lynne HedleyDirector — — Nov 17, 2026 — —
Katherine BaickerDirector — — Nov 17, 2026 — —
William G. Kaelin Jr.Director — — Nov 17, 2026 — —
David A. RicksCEO, President — — Nov 4, 2026 2 of 3 —
Kenneth L. CusterPresident — — Nov 3, 2026 — —
Edgardo HernandezEvp & Pres., Mfg. Operations — — Nov 3, 2026 — —
Adrienne S. BrownPresident — — Nov 3, 2026 — —
Eric DozierEvp, Chief People Officer — — Nov 3, 2026 — —
Lucas MontarceCFO — — Nov 3, 2026 — —
Daniel SkovronskyEvp, Cs&Po & Pres. Lrl — — Nov 3, 2026 — —
Melissa SeymourEvp, Global Quality — — Sep 11, 2026 — —
Diogo RauEvp & Cido — — Feb 12, 2026 — —
Naarden Jacob VanEvp,Pres Lly Oncology&Hdcorpbd — — Feb 11, 2026 — —

Board links: companies that share insiders with LLY

Directors and executives who filed Form 4s for LLY and another company in the last 12 months.

See the map →
  • ADBEAdobe David A. Ricks CEO, President here · Director at ADBE · latest filing Nov 4, 2026
  • ADMArcher Daniels Midland Juan R. Luciano Director here · CEO, President at ADM · latest filing Nov 17, 2026
  • AZOAutoZone Jamere Jackson Director here · CFO at AZO · latest filing Nov 17, 2026
  • IFFInternational Flavors & Fragrances J. Erik Fyrwald Director here · CEO at IFF · latest filing Nov 17, 2026
  • ILMNIllumina Daniel Skovronsky Evp, Cs&Po & Pres. Lrl here · Director at ILMN · latest filing Nov 3, 2026
  • MAMastercard Gabrielle Sulzberger Director here · Director at MA · latest filing Nov 17, 2026
  • PGProcter & Gamble Jon R. Moeller Director here · Chair at PG · latest filing Nov 17, 2026
  • TROWT. Rowe Price Kimberly H. Johnson Director here · COO at TROW · latest filing Nov 17, 2026
  • VEEVVeeva Systems Mary Lynne Hedley Director here · Director at VEEV · latest filing Nov 17, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

LLY stock: common questions

Are Lilly (Eli) insiders buying LLY stock?

No. No Lilly (Eli) insider reported an open-market purchase of LLY in the past 12 months.

Are Lilly (Eli) insiders selling LLY stock?

5 insiders reported sales worth $1.03B over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is LLY's P/E ratio?

LLY trades at about 43.9 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is LLY's 52-week range?

Over the past year LLY has traded between $848.53 and $1,443.50. It last closed at $1,353.51 on Nov 19, 2026.